Item 5.02. | Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. |
Departure of President and Chief Executive Officer
On July 26, 2022, the Company announced that President, Chief Executive Officer and Chairman of the Board, Adam J. Gilchrist, will be stepping down, effective as of July 24, 2022 (the “separation date”). Mr. Gilchrist will remain a director of the Company and the Board will appoint a new Chairman.
Mr. Gilchrist has entered into a Separation Agreement with the Company, effective as of the separation date (the “Separation Agreement”). Pursuant to the Separation Agreement, Mr. Gilchrist will remain available to provide transition services to the extent needed by the Company. Mr. Gilchrist will remain on the Board as a Class III, non-employee director.
Under the terms of the Separation Agreement, Mr. Gilchrist will be eligible to receive the following payments and benefits, subject to certain agreed conditions set forth in the Separation Agreement: (i) a one-time cash payment of $4,800,000; (ii) commencing on August 1, 2022, payment by the Company of a 12-month lease of Mr. Gilchrist’s residence in Florida, with an annual lease amount of up to $1,200,000; (iii) reimbursement for COBRA premiums for Mr. Gilchrist and his covered dependents for up to eighteen months; (iv) relocation expenses up to $20,000; (v) reimbursement of legal fees related to the Separation Agreement; and (vi) a one-time cash payment of $1,000,000. As a non-employee member of the Board, as of the separation date, Mr. Gilchrist will be eligible to receive compensation pursuant to the Company’s non-employee director compensation program, as described in the Company’s Proxy Statement for the year ended December 31, 2021, filed with the SEC on May 2, 2022.
Pursuant to the Separation Agreement, Mr. Gilchrist has also agreed to enter into an amendment to or waiver under the Company’s Third Amended and Restated Stockholders’ Agreement, dated as of July 14, 2021 (the “Stockholders’ Agreement”), filed as Exhibit 10.5 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 23, 2022 (the “2021 10-K”), to agree to certain amendments to his board nomination rights. Such board nomination rights will consist of (i) the right to designate two individuals, including Mr. Gilchrist, to be nominated for election to serve as members of the Board, for so long as Mr. Gilchrist or his affiliated entities hold at least 50% of the shares of the Company’s common stock beneficially owned by Mr. Gilchrist at the time of the Company’s initial public offering, and (ii) the right to designate one individual, including Mr. Gilchrist, to be nominated for election to serve as a member of the Board, for so long as Mr. Gilchrist or his affiliated entities hold at least 25% of the shares of the Company’s common stock beneficially owned by Mr. Gilchrist at the time of the Company’s initial public offering (in each case subject to appropriate adjustment for stock splits, dividends, recapitalizations, or similar actions).
The Company has also agreed to, as soon as practicable following the Company’s eligibility to use a registration statement on Form S-3, under the Securities Act, use commercially reasonable efforts to file a registration statement on Form S-3 to cover the resale of securities beneficially owned by Mr. Gilchrist. Certain sections of the Stockholders’ Agreement, including indemnification provisions and provisions relating to market stand-off agreements, will apply to such registration rights.
Under the Separation Agreement, Mr. Gilchrist has further agreed to certain standstill obligations for a period of one year following the separation date. Pursuant to such standstill obligations, Mr. Gilchrist and his affiliates and representatives will not, among other things, offer or propose to effect or participate in any acquisition of securities of all or substantially all of the Company’s assets, any tender or exchange offer involving the Company, any recapitalization transaction with respect to the Company, or any solicitation of proxies to vote any voting securities of the Company. Mr. Gilchrist also agreed not to form or participate in any “group” with respect to Company securities, as such term is defined under the Securities Exchange Act of 1934, as amended, or to make any public announcement with respect to an unsolicited proposal for or offer of any extraordinary transaction involving the Company or its securities.
The Separation Agreement additionally provides for a general release of claims in favor of the Company, as well as a release of claims against Mr. Gilchrist, subject to certain exceptions. The Separation Agreement includes customary cooperation, confidentiality and mutual non-disparagement provisions.